Buruli's ulcer: Three cases diagnosed and treated in France

Journal of Pediatric Orthopaedics Part B

Volumn 12, Issue 3, 2003, Pages 229-232

  Journeau, Pierre ^a,d   Fitoussi, Franck ^b   Jehanno, Pascal ^b   Padovani, Jean Paul ^c   Pennecot, Georges François ^b  

^a CENTRE HOSPITALIER DU MANS   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d CHU NANCY BRABOIS   (France)

Author keywords

Buruli's ulcer; Mycobacterium ulcerans; Skin infection

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; RIFAMPICIN;

ARTICLE; BACTERIUM CULTURE; BONE RADIOGRAPHY; BURULI ULCER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; HUMAN TISSUE; MALE; MYCOBACTERIUM ULCERANS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; SKIN ULCER; TREATMENT OUTCOME; TROPICAL DISEASE;

ANTI-BACTERIAL AGENTS; CHILD; CLARITHROMYCIN; COTE D'IVOIRE; FRANCE; HUMANS; LEG; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM ULCERANS; RIFAMPIN; SOFT TISSUE INFECTIONS;

EID: 0038248852     PISSN: 1060152X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00009957-200305000-00012     Document Type: Article

References (24)

1. Hayman J. Postulated epidemiology of Mycobacterium ulcerans infection. Int J Epidemiol 1991; 20:1093-1098.
2. Martson BJ, Diallo MO, Horsburgh CR Jr, Diomande I, Saki MZ, Kanga JM, et al. Emergence of Buruli ulcer disease in the Daloa region of Ivory Coast. Am J Trop Med Hyg 1995; 52:219-224.
3. Yoboue P, Aka B, Kanga JM. Mycobacterium skin infections. Objectif Peau 1996; 4:262-264.
4. Cornet L, Richard-Kadjo M, N'guessan HA, Yapo P, Dick R, Casanelli JM, et al. Treatment of Buruli's ulcer by excision graft. Bull Soc Pathol Exot 1992; 85:355-358.
5. Kanga JM, Kacou ED. Epidemiological aspects of Buruli ulcer in Ivory Coast: Results of National Survey. Bull Soc Pathol Exot 2001; 94:46-51.
6. Darie H, Le Guyadec T, Touze JE. Epidemiological and chemical aspects of Buruli ulcer in Ivory Coast: 124 recent cases. Bull Soc Path Exot 1993; 86:272-276.
7. Josse R, Guedenon A, Aguiar J, Anagonon S, Zinsou C, Prost C, et al. Buruli ulcer: an unknown pathology in Benin. Bull Soc Path Exot 1994; 87:170-175.
8. Fukunishi Y. Present status of Buruli ulcer in Ghana, West Africa. Nihon Hansenbyo Gakkai Zasshi 1999; 68:175-184.
9. van der Werf TS, van der Graaf WT, Tappero JW. Mycobacterium ulcerans infection. Lancet 1999; 354:1013-1018.
10. Dawson JF, Allen GE. Ulcer due to Mycobacterium ulcerans in Northern Ireland. Clin Exp Dermatol 1985; 10:572-577.
11. Aguiar J, Stenou C. Les ulcères de Buruli en zone rurale au Bénin: Prise en charge de 635 cas [in French]. Med Trop 1997; 57:83-90.
12. Asedu K, Etuaful S. Socio-economic implications of Buruli ulcer in Ghana: a three year review. Am J Trop Med Hyg 1998; 59: 1015-1022.
13. Daffe M, Varnerot A, Levy-Frebault W. The phenolic mycoside of Mycobacterium ulcerans: structure and taxonomic implications. J Gen Microbiol 1992; 138:131-137.
14. Dega H, Chosidow O, Barete S, Carbonnella B, Grosset J, Jarlier V. Mycobacterium ulcerans infection. Ann Med Interne 2000; 151:339-344.
15. George KM, Barker LP, Welty DM, Small PL. Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans. Infect Immun 1998; 66:587-593.
16. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, Small PL. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999; 283:854-857
17. George KM, Pascopella L, Welty DM, Small PL. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 2000; 68:877-883.
18. Stienstra Y, van der Graaf WT, Meerman GJ, The TH, de Leij LF, van der Werf TS. Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health 2000; 6: 554-562.
19. Muelder K. Wounds that will not heal the Buruli Ulcer. Int J Dermatol 1992; 31:25-26.
20. Parez JJ, Fauville-Dufaux M, Dossogne JL, De Hoffmann E, Pouthier F. Faster identification of mycobacterium using gas liquid and thin layer chromatography. Eur J Chin Microbiol Infect Dis 1994; 13:715-725.
21. Darie H, Djakeaux S, Cautoclaud A. Therapeutic approach in Mycobacterium ulcerans infections. Bull Soc Path Exot 1994; 87: 19-21.
22. Song M, Vineke G, Vanuebter H, Benekens J, Chten G. Treatment of cutaneous infection due to Mycobacterium ulcerans. Dermatologica 1985; 171:197-199.
23. Lagarrigue V, Portaels F, Meyers WM, Aguiar J. Buruli ulcer: risk of bone involvement. A propos of 33 cases observed in Benin. Med Trop 2000; 60:262-266.
24. Portaels F, Traore H, De Ridder K, Meyers WM. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother 1998; 42:2070-2073.